PL3041831T3 - Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby - Google Patents
Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia chorobyInfo
- Publication number
- PL3041831T3 PL3041831T3 PL14767252T PL14767252T PL3041831T3 PL 3041831 T3 PL3041831 T3 PL 3041831T3 PL 14767252 T PL14767252 T PL 14767252T PL 14767252 T PL14767252 T PL 14767252T PL 3041831 T3 PL3041831 T3 PL 3041831T3
- Authority
- PL
- Poland
- Prior art keywords
- alpha
- compositions
- salt forms
- treating disease
- tea salt
- Prior art date
Links
- LCFWOFKPFDWYLR-CEFNRUSXSA-N alpha-tocopheryloxyacetic acid Chemical group OC(=O)COC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C LCFWOFKPFDWYLR-CEFNRUSXSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874823P | 2013-09-06 | 2013-09-06 | |
| PCT/US2014/054354 WO2015035212A1 (en) | 2013-09-06 | 2014-09-05 | Alpha-tea salt forms: compositions and uses for treating disease |
| EP14767252.1A EP3041831B1 (en) | 2013-09-06 | 2014-09-05 | Alpha-tea salt forms: compositions and uses for treating disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3041831T3 true PL3041831T3 (pl) | 2021-07-19 |
Family
ID=51570908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14767252T PL3041831T3 (pl) | 2013-09-06 | 2014-09-05 | Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10370350B2 (enExample) |
| EP (1) | EP3041831B1 (enExample) |
| JP (2) | JP6675985B2 (enExample) |
| AU (1) | AU2014318014C1 (enExample) |
| CA (1) | CA2922375C (enExample) |
| DK (1) | DK3041831T3 (enExample) |
| ES (1) | ES2766324T3 (enExample) |
| PL (1) | PL3041831T3 (enExample) |
| WO (1) | WO2015035212A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014318014C1 (en) | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
| GB201701194D0 (en) | 2017-01-24 | 2017-03-08 | Capella Bioscience Ltd | Antigen binding molecules that bind light |
| CN107050432B (zh) * | 2017-02-28 | 2019-09-10 | 上海交通大学医学院 | 胃泌素在制备诊断和治疗乳腺癌药物中的应用 |
| US11312781B2 (en) | 2018-01-24 | 2022-04-26 | Capella Bioscience Ltd. | Antigen binding molecules that bind LIGHT |
| EP3646873A1 (en) * | 2018-10-31 | 2020-05-06 | Aprofol AG | Folate salts |
| CN111635390A (zh) * | 2020-06-30 | 2020-09-08 | 江南大学 | 一种低泡型α-生育酚表面活性剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4629734Y1 (enExample) | 1968-04-23 | 1971-10-14 | ||
| US4861580A (en) | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
| JP2634047B2 (ja) * | 1985-10-15 | 1997-07-23 | ザ リポソ−ム カンパニ−，インコ−ポレイテツド | アルファトコフェロールをベースとした小胞体 |
| US6770672B1 (en) | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| RU2232758C2 (ru) * | 1998-09-23 | 2004-07-20 | Рисерч Дивелопмент Фаундейшн | Токоферолы, токотриенолы и другие производные хромана и боковых цепей и способы лечения с их использованием |
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| AU2001236805B2 (en) | 2000-02-11 | 2005-07-14 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| ATE468109T1 (de) * | 2001-12-19 | 2010-06-15 | Res Dev Foundation | Liposomale abgabe von verbindungen auf vitamin-e- basis |
| AU2014318014C1 (en) | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
-
2014
- 2014-09-05 AU AU2014318014A patent/AU2014318014C1/en active Active
- 2014-09-05 EP EP14767252.1A patent/EP3041831B1/en active Active
- 2014-09-05 PL PL14767252T patent/PL3041831T3/pl unknown
- 2014-09-05 DK DK14767252.1T patent/DK3041831T3/da active
- 2014-09-05 WO PCT/US2014/054354 patent/WO2015035212A1/en not_active Ceased
- 2014-09-05 US US14/916,271 patent/US10370350B2/en active Active
- 2014-09-05 JP JP2016540431A patent/JP6675985B2/ja active Active
- 2014-09-05 ES ES14767252T patent/ES2766324T3/es active Active
- 2014-09-05 CA CA2922375A patent/CA2922375C/en active Active
-
2019
- 2019-06-18 US US16/443,911 patent/US10934267B2/en active Active
- 2019-12-23 JP JP2019231273A patent/JP2020063294A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK3041831T3 (da) | 2020-01-27 |
| ES2766324T3 (es) | 2020-06-12 |
| CA2922375A1 (en) | 2015-03-12 |
| US20200148661A1 (en) | 2020-05-14 |
| JP2020063294A (ja) | 2020-04-23 |
| AU2014318014A1 (en) | 2016-03-17 |
| EP3041831A1 (en) | 2016-07-13 |
| JP2016532714A (ja) | 2016-10-20 |
| AU2014318014C1 (en) | 2018-11-15 |
| US10370350B2 (en) | 2019-08-06 |
| US10934267B2 (en) | 2021-03-02 |
| US20160214954A1 (en) | 2016-07-28 |
| WO2015035212A1 (en) | 2015-03-12 |
| EP3041831B1 (en) | 2019-10-23 |
| CA2922375C (en) | 2021-06-15 |
| JP6675985B2 (ja) | 2020-04-08 |
| AU2014318014B2 (en) | 2018-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201601024B (en) | Methods and compositions for treating brain diseases | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| ZA201505390B (en) | Compositions and methods for treating pests | |
| SG10201707319UA (en) | Compositions and methods for treating mpsi | |
| EP2958936A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE | |
| ZA201506487B (en) | Therapeutic compounds and compositions | |
| IL239921A0 (en) | Preparations containing solutions in solid state and their use for the treatment of pain | |
| SG11201506713TA (en) | 2-acylaminothiazole derivative and salt thereof | |
| SG10201710538XA (en) | Compositions and methods for treating skin | |
| HUE050413T2 (hu) | Kompozíciók és eljárások fertõzéses megbetegedés kezelésére | |
| GB201304872D0 (en) | Treatment | |
| PL3041831T3 (pl) | Postacie soli alfa-TEA: kompozycje i zastosowania do leczenia choroby | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| EP2952194A4 (en) | EMULSION COMPOSITION | |
| ZA201509360B (en) | Compositions and methods for treatment of stroke | |
| ZA201507015B (en) | Composition for treating hemorrhoids | |
| EP2968550A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS RELATED DISORDERS | |
| GB201307310D0 (en) | Treatment | |
| IL245452A0 (en) | Salts of Armachol | |
| GB201321628D0 (en) | Treatment of disease | |
| ZA201407032B (en) | Preventing or treating periodontal disease | |
| GB201321115D0 (en) | Treatment | |
| GB201302472D0 (en) | Compositions and methods for treating biofilms | |
| GB201302474D0 (en) | Compositions and methods for treating biofilms | |
| GB201302475D0 (en) | Compositions and methods for treating biofilms |